Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Kiang, KM, Bryant, PA, Shingadia, D, Ladhani, S, Steer, AC, Burgner, D.
The treatment of imported malaria in children: an update..
Arch Dis Child Educ Pract Ed
98(1)
:
7 -15
2013
view publication
Burns, JC, Herzog, L, Fabri, O, Tremoulet, AH, Rodó, X, Uehara, R, Burgner, D, Bainto, E, Pierce, D, Tyree, M, et al.
Seasonality of Kawasaki disease: a global perspective..
PLoS One
8(9)
:
e74529
2013
view publication
Chang, C-J, Kuo, H-C, Chang, J-S, Lee, J-K, Tsai, F-J, Khor, CC, Chang, L-C, Chen, S-P, Ko, T-M, Liu, Y-M, et al.
Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility..
PLoS One
8(8)
:
e72037
2013
view publication
Mohd Abd Rahman, M, Bryant, P, Guppy, D, Buttery, J, Burgner, D.
Intermittent fever, splenomegaly and eosinophilia in a recently resettled African refugee..
J Paediatr Child Health
48(10)
:
939 -941
2012
view publication
Tacke, CE, Burgner, D, Kuipers, IM, Kuijpers, TW.
Management of acute and refractory Kawasaki disease..
Expert Rev Anti Infect Ther
10(10)
:
1203 -1215
2012
view publication